Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Goulder

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Plos Pathogens|September 16, 2021
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patientsJonathan Youngs, Nicholas M Provine, Nicholas Lim, et al.
AIDS (London, England)|February 6, 2025
Long-term non-progression in children with HIV: estimates from international cohort dataCharlotte Jackson, Siobhan Crichton, Ali Judd, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapyMohammed Altaf, Carla Nel, Timothy Tipoe, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Plos Pathogens|September 16, 2021
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patientsJonathan Youngs, Nicholas M Provine, Nicholas Lim, et al.
AIDS (London, England)|February 6, 2025
Long-term non-progression in children with HIV: estimates from international cohort dataCharlotte Jackson, Siobhan Crichton, Ali Judd, et al.
Nature Communications|August 18, 2021
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concernDonal T Skelly, Adam C Harding, Javier Gilbert-Jaramillo, et al.
Nature Medicine|February 5, 2025
Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapyMohammed Altaf, Carla Nel, Timothy Tipoe, et al.
Cell|June 30, 2022
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serumAekkachai Tuekprakhon, Rungtiwa Nutalai, Aiste Dijokaite-Guraliuc, et al.
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
Journal of Virology|November 24, 2017
Differential Immunodominance Hierarchy of CD8<sup>+</sup> T-Cell Responses in HLA-B*27:05- and -B*27:02-Mediated Control of HIV-1 InfectionEmily Adland, Matilda Hill, Nora Lavandier, et al.
Nature Medicine|June 6, 2024
Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmissionNomonde Bengu, Gabriela Cromhout, Emily Adland, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Pageof 12